218 related articles for article (PubMed ID: 25615557)
21. Blood plasma surface-enhanced Raman spectroscopy for non-invasive optical detection of cervical cancer.
Feng S; Lin D; Lin J; Li B; Huang Z; Chen G; Zhang W; Wang L; Pan J; Chen R; Zeng H
Analyst; 2013 Jul; 138(14):3967-74. PubMed ID: 23529624
[TBL] [Abstract][Full Text] [Related]
22. Novel chemometrics‑assisted spectroscopic methods for diagnosis and monitoring of invasive ductal carcinoma in breast tissue.
Albayrak M; Senol O; Demirkaya-Miloglu F; Calik M; Kadioglu Y
Bratisl Lek Listy; 2019; 120(3):184-187. PubMed ID: 31023035
[TBL] [Abstract][Full Text] [Related]
23. The biochemical, nanomechanical and chemometric signatures of brain cancer.
Abramczyk H; Imiela A
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jan; 188():8-19. PubMed ID: 28688336
[TBL] [Abstract][Full Text] [Related]
24. Benign proliferative lesions and in situ carcinoma of the breast: new immunohistological findings and their biological implications.
Böcker W; Bier B; Ludwig A; de Hesselle B; Gerdes J
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():41-9. PubMed ID: 7507748
[No Abstract] [Full Text] [Related]
25. Diagnosis of breast cancer using diffuse reflectance spectroscopy: Comparison of a Monte Carlo versus partial least squares analysis based feature extraction technique.
Zhu C; Palmer GM; Breslin TM; Harter J; Ramanujam N
Lasers Surg Med; 2006 Aug; 38(7):714-24. PubMed ID: 16799981
[TBL] [Abstract][Full Text] [Related]
26. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
Calzada L; Salazar EL; Pedron Nuevo N
Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
[TBL] [Abstract][Full Text] [Related]
27. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
29. Metaplastic carcinoma of the breast.
Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
[TBL] [Abstract][Full Text] [Related]
30. Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy.
Marro M; Nieva C; Sanz-Pamplona R; Sierra A
Biochim Biophys Acta; 2014 Sep; 1843(9):1785-95. PubMed ID: 24747691
[TBL] [Abstract][Full Text] [Related]
31. SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas.
Traub F; Feist H; Kreipe HH; Pich A
Pathol Res Pract; 2005; 201(12):763-70. PubMed ID: 16308101
[TBL] [Abstract][Full Text] [Related]
32. Discriminating isogenic cancer cells and identifying altered unsaturated fatty acid content as associated with metastasis status, using k-means clustering and partial least squares-discriminant analysis of Raman maps.
Hedegaard M; Krafft C; Ditzel HJ; Johansen LE; Hassing S; Popp J
Anal Chem; 2010 Apr; 82(7):2797-802. PubMed ID: 20187629
[TBL] [Abstract][Full Text] [Related]
33. Discrimination of breast cancer from benign tumours using Raman spectroscopy.
Lyng FM; Traynor D; Nguyen TNQ; Meade AD; Rakib F; Al-Saady R; Goormaghtigh E; Al-Saad K; Ali MH
PLoS One; 2019; 14(2):e0212376. PubMed ID: 30763392
[TBL] [Abstract][Full Text] [Related]
34. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes.
Buerger H; Otterbach F; Simon R; Schäfer KL; Poremba C; Diallo R; Brinkschmidt C; Dockhorn-Dworniczak B; Boecker W
J Pathol; 1999 Dec; 189(4):521-6. PubMed ID: 10629552
[TBL] [Abstract][Full Text] [Related]
35. Histology and immunophenotype of invasive lobular breast cancer. daily practice and pitfalls.
Varga Z; Mallon E
Breast Dis; 2008-2009; 30():15-9. PubMed ID: 19850991
[TBL] [Abstract][Full Text] [Related]
36. Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS).
Gebrekidan MT; Erber R; Hartmann A; Fasching PA; Emons J; Beckmann MW; Braeuer A
Technol Cancer Res Treat; 2018 Jan; 17():1533033818782532. PubMed ID: 29991340
[TBL] [Abstract][Full Text] [Related]
37. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
Lee AH; Dublin EA; Bobrow LG; Poulsom R
J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
[TBL] [Abstract][Full Text] [Related]
38. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll R; Mitze M; Frixen UH; Birchmeier W
Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
[TBL] [Abstract][Full Text] [Related]
39. Differentiation between cancerous and normal hyperplastic lobules in breast lesions.
Slater M; Danieletto S; Pooley M; Cheng Teh L; Gidley-Baird A; Barden JA
Breast Cancer Res Treat; 2004 Jan; 83(1):1-10. PubMed ID: 14997049
[TBL] [Abstract][Full Text] [Related]
40. [A comparative morphometric analysis of cytograms of invasive ductal and invasive lobular breast cancer].
Volchenko NN; Medovyĭ VS; Slavnova EN; Savostikova MV; Medovyĭ VS; Sokolinskiĭ BZ; Klimova NV
Arkh Patol; 2002; 64(6):37-9. PubMed ID: 12534227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
